109 related articles for article (PubMed ID: 2439576)
1. In vivo study of the mechanism of action of antiviral agents against hepadna virus replication in the liver. Resistance of supercoiled viral DNA.
Omata M; Hirota K; Yokosuka O
J Hepatol; 1986; 3 Suppl 2():S49-55. PubMed ID: 2439576
[TBL] [Abstract][Full Text] [Related]
2. Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection.
Hirota K; Sherker AH; Omata M; Yokosuka O; Okuda K
Hepatology; 1987; 7(1):24-8. PubMed ID: 3804202
[TBL] [Abstract][Full Text] [Related]
3. Effects of adenine arabinoside and corticosteroid on replication of duck hepatitis B virus DNA in the liver.
Hirota K; Sherker AH; Omata M; Yokosuka O; Okuda K
Ann Acad Med Singap; 1986 Apr; 15(2):227-32. PubMed ID: 3752897
[TBL] [Abstract][Full Text] [Related]
4. Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.
Civitico G; Wang YY; Luscombe C; Bishop N; Tachedjian G; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):90-7. PubMed ID: 1696959
[TBL] [Abstract][Full Text] [Related]
5. Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks.
Fourel I; Li J; Hantz O; Jacquet C; Fox JJ; Trépo C
J Med Virol; 1992 Jun; 37(2):122-6. PubMed ID: 1629711
[TBL] [Abstract][Full Text] [Related]
6. An in vitro system for screening anti-hepatitis B virus drugs.
Ueda K; Tsurimoto T; Nagahata T; Chisaka O; Matsubara K
Virology; 1989 Mar; 169(1):213-6. PubMed ID: 2466368
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model.
Nagahata T; Araki K; Yamamura K; Matsubara K
Antimicrob Agents Chemother; 1992 Sep; 36(9):2042-5. PubMed ID: 1416898
[TBL] [Abstract][Full Text] [Related]
8. Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.
Li Y; Liu Z; Hui L; Liu X; Feng A; Wang W; Zhang L; Li N; Zhou G; Wang Q; Han Q; Lv Y; Wang Q; Yang G; Wang Y
Br J Pharmacol; 2017 Jul; 174(14):2261-2272. PubMed ID: 28383135
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
[TBL] [Abstract][Full Text] [Related]
10. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo.
Bingfa X; Qinglin F; Hui H; Canjun W; Wei W; Lihua S
Pharmacology; 2009; 83(6):323-32. PubMed ID: 19407486
[TBL] [Abstract][Full Text] [Related]
11. The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.
Niu J; Wang Y; Dixon R; Bowden S; Qiao M; Einck L; Locarnini S
Antiviral Res; 1993 Jun; 21(2):155-71. PubMed ID: 7687840
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
[TBL] [Abstract][Full Text] [Related]
13. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Sherker AH; Hirota K; Omata M; Okuda K
Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
[TBL] [Abstract][Full Text] [Related]
14. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
15. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.
Li J; Huang H; Feng M; Zhou W; Shi X; Zhou P
Antiviral Res; 2008 Aug; 79(2):114-20. PubMed ID: 18423640
[TBL] [Abstract][Full Text] [Related]
17. [The present state of research in direct antiviral mechanism of interferon on hepatitis B virus].
Liu F; Tang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Dec; 26(6):1358-62, 1371. PubMed ID: 20095503
[TBL] [Abstract][Full Text] [Related]
18. [Effects of adenine arabinoside on duck hepatitis B virus infection. Analysis of intrahepatic replicative DNA].
Hirota K; Omata M; Yokosuka O; Imazeki F; Uchiumi K; Ito Y; Okuda K
Nihon Shokakibyo Gakkai Zasshi; 1987 Jan; 84(1):58-64. PubMed ID: 3573385
[No Abstract] [Full Text] [Related]
19. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus.
Isorce N; Testoni B; Locatelli M; Fresquet J; Rivoire M; Luangsay S; Zoulim F; Durantel D
Antiviral Res; 2016 Jun; 130():36-45. PubMed ID: 26971407
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
